Starling Oncology Emerges from TOI Rebrand with Nasdaq Ticker Change
Event summary
- The Oncology Institute rebrands as Starling Oncology, effective August 3, 2026.
- Nasdaq ticker changes from TOI to STLN starting August 4, 2026.
- Company operates 100+ clinics across five states with 400+ clinicians.
- Serves approximately 2.1 million patients with value-based cancer care.
The big picture
Starling Oncology's rebrand reflects a shift from traditional oncology practice to an integrated platform model, aligning with broader industry trends toward value-based care. The move underscores the company's ambition to address rising oncology costs while expanding its footprint in community-based cancer treatment.
What we're watching
- Scaling Strategy
- Whether Starling Oncology can sustain its growth trajectory across expanding markets while maintaining care quality.
- Market Differentiation
- How the rebrand positions Starling Oncology against competitors in the value-based oncology space.
- Operational Integration
- The pace at which Starling Oncology integrates its technology-enabled care model across new locations.
Related topics